E-Alterantive Solutions (EAS) has submitted Premarket Tobacco Product Applications (PTMAs) to the U.S. Food and Drug Administration for various products within its Leap and Leap Go vapor product portfolios. By submitting these applications, EAS is seeking authorization to market and sell its vapor products lawfully within the U.S.
“We are pleased to take this important step in demonstrating our commitment to the vapor industry, retailers and adult smokers seeking an alternative to combustible cigarette smoking with our Leap and Leap Go vapor products,” commented Jacopo D’Alessandris, president and CEO of EAS. “At EAS, we have always held ourselves to high standards, from supplying adult consumers with products they can trust to consistently following ethical marketing practices. We are confident in the strong merits of our PMTAs and want to thank our compliance and research teams for developing and delivering thorough submissions.”
Part of EAS’ PMTA applications include 75,000 pages worth of assessment of the stability of the products over time, toxicological formula reviews, toxicology testing, an assessment of abuse liability, label comprehension studies and behavioral studies. In addition, EAS undertook an extensive review of available literature on vapor products related to health effects, behavioral factors and toxicological end points. The filing also included a risk assessment of the potential risk for Leap and Leap Go products.
 with the FDA for several of its Leap and Leap Go vapor products.){kind=link}